Navigation Links
Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine
Date:2/16/2017

MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by Fortune.

The annual survey designated Quest Diagnostics as one of only six companies in the "Health Care: Pharmacy and Other Services" industry to attain Most Admired status, and the only diagnostic information services company to attain the designation. This is the second consecutive year Quest has attained the Most Admired designation.

"We are honored to be included once again among this prestigious group of companies attaining this distinction," said Steve Rusckowski, Chairman, President and CEO. "Our 43,000 dedicated employees are leading the way in delivering the diagnostic insights which empower people to take action to improve health outcomes."

Fortune's "World's Most Admired Companies" list is based on surveys of 680 companies from 28 countries asking executives, directors and analysts to rate companies within their own industry on nine reputation drivers considered to be crucial to a company's global success. These drivers include financial soundness, long-term investment value, people management, social responsibility, use of assets, quality of management, quality of products/services, innovation and global competitiveness.

About Quest Diagnostics

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Quest Diagnostics Contacts: Shawn Bevec (Investors): 973-520-2900 Denny Moynihan (Media): 973-520-2800

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quest-diagnostics-named-one-of-2017-worlds-most-admired-companies-by-fortune-magazine-300409028.html


'/>"/>
SOURCE Quest Diagnostics
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Immune Pharmaceuticals Will Request an Appeal to Regain Compliance with Nasdaqs Minimum Bid Price Rule
2. Research Reports Initiation on Medical Research Stocks -- Quest Diagnostics, DexCom, Organovo, and Alere
3. If You Have Questions about Medicare Part D, Let freds Pharmacy Help
4. IBBR Request for Proposals (RFP) - GMP Bio-manufacturing Facility Available
5. "But Will It Cover Cancer?": Treato Examines the Questions and Criticism of Obamacare
6. Missed Questions, Missed Opportunities
7. Quest Diagnostics Expands Dakos PD-L1 IHC 28-8 Complementary Test to Include Melanoma
8. Europe Vitamin D Testing Market Analysis 2015-2019 - Key Vendors are Abbott Diagnostics, Biomeriux, Diasorin, Quest Diagnostics, Roche Diagnostics & Siemens Healthcare Diagnostics
9. Juniper Pharmaceuticals Expands Lead Phase 2b Trial, Submits Pre-IND Meeting Request for its First Intra-vaginal Ring Product, and Adds Four Key Executives
10. KaloBios Pharmaceuticals, Inc. Announces Submission of Request for Appeal of Nasdaq Delisting
11. Amarantus Requests Rare Pediatric Disease and Orphan Drug Designations from US FDA for Engineered Skin Substitute in the Treatment of Giant Congenital Melanocytic Nevi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):